A number of biomarkers identified here are consistent with those reported in the literature in terms of their altered gene expressions in tumor tissues, including caveolin 1 [8], [9], cyclin B1 [10], [11], 14-3-3zeta [14], Stat5 [15], activated p38 [16], and IGFBP2 [17]. The gene discussed is CCNB1; the disease is neoplasm.